23Sep/13

Difficulties in extending patent protection for uses of known drugs in Europe … – Lexology (registration)

Difficulties in extending patent protection for uses of known drugs in Europe
Lexology (registration)
A case in point is the recent EPO Board of Appeals decision in T0734/12 in relation to a patent (EP1613350) in which Genentech claimed use of rituximab (Rituxan®) to treat patients who were suffering from rheumatoid arthritis (RA) who were refractory

23Sep/13

Symptoms of heart diseases and prevention – Times of India


Times of India

Symptoms of heart diseases and prevention
Times of India
The most common heart diseases plaguing Indians between the age group of 25-60 are cardiovascular diseases, cardiac arrests, congestive heart failures, coronary heart diseases, rheumatic heart diseases and strokes. Dr Tilak Suvarna, Interventional 
What you eat has big impact on heart’s healthArab Times Kuwait English Daily

all 3 news articles »

23Sep/13

A hidden heart disease that's often misdiagnosed – Boston Globe


Boston Globe

A hidden heart disease that’s often misdiagnosed
Boston Globe
Two years ago, Thomas Fiorito, 59, was told to get his affairs in order by his doctors at Emory University Hospital in Atlanta; his amyloidosis was causing severe heart failure that would likely kill him in a few months. Like Cohen, his doctors also
Amyloidosis: A hidden cause of heart failure that’s often underdiagnosedBoston.com

all 2 news articles »

23Sep/13

Biogen Idec presenterà all'ECTRIMS numerosi nuovi dati relativi alla suo ampia … – Teleborsa


Teleborsa

Biogen Idec presenterà all’ECTRIMS numerosi nuovi dati relativi alla suo ampia
Teleborsa
PROCESSO DACLIZUMAB AD ELEVATO RENDIMENTO (DAC HYP): in fase di sviluppo come iniezione sottocutanea da somministrare mensilmente. Si ritiene che DAC HYP abbia come target le cellule immunitarie attive che possono giocare un ruolo 

and more »